Skip to main content
Apyx Medical Corp logo

Apyx Medical Corp — Investor Relations & Filings

Ticker · APYX ISIN · US0323472052 LEI · 5299009QZVYUYO082S45 US Manufacturing
Open in API
Filings indexed 969 across all filing types
Latest filing 2005-09-02 Regulatory Filings
Country US United States of America
Listing US APYX

About Apyx Medical Corp

https://apyxmedical.com/

Apyx Medical Corporation is an advanced energy technology company that develops, manufactures, and markets innovative products for surgical and cosmetic markets. The company's proprietary Helium Plasma Platform, which is the foundation for its Renuvion® and J-Plasma® brands, utilizes a unique combination of helium plasma and radiofrequency (RF) energy. These systems are designed to deliver controlled energy for the cutting, coagulation, and ablation of soft tissue, with a primary focus on aesthetic procedures for skin tightening and body contouring. Apyx Medical, formerly Bovie Medical, leverages its expertise in energy-based waveforms to provide transformative solutions for surgeons and their patients.

Recent filings

Filing Released Lang Actions
AMENDMENT #6 TO FORM S-3/A
Regulatory Filings Classification · 100% confidence The document is an Amendment No. 6 to Form S-3/A, which is a registration statement filed under the Securities Act of 1933. It primarily consists of signature pages and clarifications related to the registration statement, not financial statements or performance data. The document length is short (3002 characters) and it does not contain financial results or detailed disclosures typical of annual or quarterly reports. It is not an earnings release, management report, or any other detailed financial filing. Instead, it is a regulatory filing related to securities registration and amendments thereof. Therefore, the appropriate classification is Regulatory Filings (RNS).
2005-09-02 English
Regulatory Filings 2005
Regulatory Filings
2005-08-31 English
S-3A 5TH
Capital/Financing Update Classification · 100% confidence The document is a Form S-3/A5 Registration Statement filed with the SEC under the Securities Act of 1933 by Bovie Medical Corporation. It is a registration statement for the public offering of common stock shares by selling stockholders. The document includes detailed information about the offering, risk factors, company summary, and legal disclaimers. It is not an annual report, earnings release, or any other financial report but a capital markets filing related to securities registration and offering. This fits the definition of a Capital/Financing Update (CAP) as it updates on company fundraising and capital structure changes through a securities registration statement.
2005-08-25 English
FORM 10KSB/A DECEMBER 31, 2004
Annual Report Classification · 100% confidence The document is titled 'FORM 10-KSB/A' and is an amendment to the annual report for the fiscal year ended December 31, 2004. It is filed with the U.S. Securities and Exchange Commission under the Securities Exchange Act of 1934. The content includes detailed business description, product lines, development activities, manufacturing, marketing, and competition, which are typical components of an annual report. The document length is substantial (15,000 characters), indicating it is the full report or a significant amendment, not just an announcement or certification. Therefore, this document is classified as an Annual Report (10-K).
2005-08-25 English
FORM 10-QSB/A JUNE 30, 2005
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB/A' and is a quarterly report amendment for the period ended June 30, 2005. It includes detailed disclosures about controls and procedures, certifications by the CEO and CFO pursuant to Sarbanes-Oxley Act sections, and signatures. The presence of actual financial reporting content and the SEC form type 10-QSB/A clearly identifies this as an amended quarterly report. The document length is 4408 characters, which is sufficient to contain substantive financial and operational information, not just an announcement or certification. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2005-08-25 English
FORM 10-QSB/A MARCH 31, 2005
Interim / Quarterly Report Classification · 95% confidence The document is titled 'FORM 10-QSB/A' for the quarterly period ended March 31, 2005, which indicates it is an amended quarterly report filed pursuant to the Securities Exchange Act of 1934. It contains sections on controls and procedures, certifications by the CEO and CFO pursuant to Sarbanes-Oxley Act rules, and signatures. The document includes actual financial reporting controls information and is not merely an announcement or certification alone. The length is 4438 characters, which is relatively short but sufficient for an amended quarterly report. Therefore, this document is best classified as an Interim / Quarterly Report (IR).
2005-08-25 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.